Changing the management of advanced penile cancer

Penile squamous cell carcinoma (PSCC) constitutes a rare, yet clinically relevant malignancy, representing approximately 1% of all new cancer cases in males worldwide; a total of 37,700 new cases and 17,000 deaths due to PSCC are expected annually.1 In Europe and in the United States, about 7,000 and 2,000 men are diagnosed with PSCC per year respectively, while in Latin…